List of works - Soji Kakiuchi

5-Aminolevulinic acid-induced fluorescence diagnosis of pleural malignant tumor ⬇️

scientific article published on February 26, 2011

A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient mice

scientific article published on January 2009

A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer ⬇️

scientific article published on March 10, 2011

A novel targeting therapy of malignant mesothelioma using anti-podoplanin antibody.

scientific article published on 20 May 2013

Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1.

scientific article

Analysis of the Prognostic Factors of Extensive Disease Small-Cell Lung Cancer Patients in Tokushima University Hospital.

scientific article published on January 2016

Antitumor vascular strategy for controlling experimental metastatic spread of human small-cell lung cancer cells with ZD6474 in natural killer cell-depleted severe combined immunodeficient mice.

scientific article published on December 2005

Characteristics of and risk factors for interstitial lung disease induced by chemotherapy for lung cancer

scientific article published on 6 January 2015

Development of individualized therapy of non-small cell lung cancer targeted at the EGF receptor

scientific article

Dll4-Fc, an inhibitor of Dll4-notch signaling, suppresses liver metastasis of small cell lung cancer cells through the downregulation of the NF-κB activity

scientific article published on 18 September 2012

E7080 suppresses hematogenous multiple organ metastases of lung cancer cells with nonmutated epidermal growth factor receptor.

scientific article published on 6 May 2011

E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.

scientific article

Epidemiological and clinical features of lung cancer patients from 1999 to 2009 in Tokushima Prefecture of Japan ⬇️

scientific article published on August 1, 2010

Epidermal growth factor receptor-tyrosine kinase inhibitor (gefitinib) augments pneumonitis, but attenuates lung fibrosis in response to radiation injury in rats ⬇️

scientific article published on 01 January 2012

Erlotinib prevents experimental metastases of human small cell lung cancer cells with no epidermal growth factor receptor expression.

scientific article

Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs

scientific article

Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab.

scientific article published on 4 December 2015

Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice

scientific article

Gender difference in bone metastasis of human small cell lung cancer, SBC-5 cells in natural killer-cell depleted severe combined immunodeficient mice

scientific article

Gene-expression profiles of human tumor xenografts in nude mice treated orally with the EGFR tyrosine kinase inhibitor ZD1839.

scientific article

Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice ⬇️

scientific article published on 01 May 2003

Genome-wide profiling of gene expression in 29 normal human tissues with a cDNA microarray

scientific article

HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody

scientific article published in November 2008

Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations.

scientific article

Identification of genes potentially involved in bone metastasis by genome-wide gene expression profile analysis of non-small cell lung cancer in mice ⬇️

scientific article published on January 27, 2012

Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic target

scientific article published on August 2013

Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice.

scientific article

Investigation of the outpatient chemotherapy for lung cancer patients in Tokushima University Hospital

scientific article published in August 2011

Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusions

scientific article published on 01 February 2007

Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2.

scientific article

Macrophage stimulating protein promotes liver metastases of small cell lung cancer cells by affecting the organ microenvironment ⬇️

scientific article published on September 26, 2012

Molecular targeting in the treatment of lung cancer--toward the development of individualized treatment

scientific article published on September 2004

Novel dual targeting strategy with vandetanib induces tumor cell apoptosis and inhibits angiogenesis in malignant pleural mesothelioma cells expressing RET oncogenic rearrangement.

scientific article

Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES-10 cells) highly expressing vascular endothelial growth factor and its receptor.

scientific article published on March 2006

Pemetrexed-Induced Rash May Be Prevented by Supplementary Corticosteroids

scientific article published on 01 January 2015

Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer

scientific article

Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839).

scientific article published on 20 October 2004

Retreatment of lung adenocarcinoma patients with gefitinib who had experienced favorable results from their initial treatment with this selective epidermal growth factor receptor inhibitor: a report of three cases.

scientific article published on January 2005

Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity

scientific article published on December 2005

SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model

scientific article published on August 2012

Study on the Optimal Dose of Irinotecan for Patients with Heterozygous Uridine Diphosphate-Glucuronosyltransferase 1A1 (UGT1A1)

scientific article published on 01 January 2019

Surfactant protein A suppresses lung cancer progression by regulating the polarization of tumor-associated macrophages.

scientific article published on 14 March 2013

The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice ⬇️

scientific article published on November 16, 2010

[Bridging between molecular biology and clinical aspect of respiratory tract diseases: discussion]

scientific article published on 01 July 2003

[Clinical evaluation of molecular-target based drug]

scientific article published on 01 July 2004

List of works by Soji Kakiuchi

5-Aminolevulinic acid-induced fluorescence diagnosis of pleural malignant tumor ⬇️

A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient mice

A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer ⬇️

A novel targeting therapy of malignant mesothelioma using anti-podoplanin antibody.

Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1.

Analysis of the Prognostic Factors of Extensive Disease Small-Cell Lung Cancer Patients in Tokushima University Hospital.

Antitumor vascular strategy for controlling experimental metastatic spread of human small-cell lung cancer cells with ZD6474 in natural killer cell-depleted severe combined immunodeficient mice.

Characteristics of and risk factors for interstitial lung disease induced by chemotherapy for lung cancer

Development of individualized therapy of non-small cell lung cancer targeted at the EGF receptor

Dll4-Fc, an inhibitor of Dll4-notch signaling, suppresses liver metastasis of small cell lung cancer cells through the downregulation of the NF-κB activity

E7080 suppresses hematogenous multiple organ metastases of lung cancer cells with nonmutated epidermal growth factor receptor.

E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.

Epidemiological and clinical features of lung cancer patients from 1999 to 2009 in Tokushima Prefecture of Japan ⬇️

Epidermal growth factor receptor-tyrosine kinase inhibitor (gefitinib) augments pneumonitis, but attenuates lung fibrosis in response to radiation injury in rats ⬇️

Erlotinib prevents experimental metastases of human small cell lung cancer cells with no epidermal growth factor receptor expression.

Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs

Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab.

Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice

Gender difference in bone metastasis of human small cell lung cancer, SBC-5 cells in natural killer-cell depleted severe combined immunodeficient mice

Gene-expression profiles of human tumor xenografts in nude mice treated orally with the EGFR tyrosine kinase inhibitor ZD1839.

Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice ⬇️

Genome-wide profiling of gene expression in 29 normal human tissues with a cDNA microarray

HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody

Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations.

Identification of genes potentially involved in bone metastasis by genome-wide gene expression profile analysis of non-small cell lung cancer in mice ⬇️

Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic target

Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice.

Investigation of the outpatient chemotherapy for lung cancer patients in Tokushima University Hospital

Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusions

Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2.

Macrophage stimulating protein promotes liver metastases of small cell lung cancer cells by affecting the organ microenvironment ⬇️

Molecular targeting in the treatment of lung cancer--toward the development of individualized treatment

Novel dual targeting strategy with vandetanib induces tumor cell apoptosis and inhibits angiogenesis in malignant pleural mesothelioma cells expressing RET oncogenic rearrangement.

Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES-10 cells) highly expressing vascular endothelial growth factor and its receptor.

Pemetrexed-Induced Rash May Be Prevented by Supplementary Corticosteroids

Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer

Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839).

Retreatment of lung adenocarcinoma patients with gefitinib who had experienced favorable results from their initial treatment with this selective epidermal growth factor receptor inhibitor: a report of three cases.

Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity

SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model

Study on the Optimal Dose of Irinotecan for Patients with Heterozygous Uridine Diphosphate-Glucuronosyltransferase 1A1 (UGT1A1)

Surfactant protein A suppresses lung cancer progression by regulating the polarization of tumor-associated macrophages.

The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice ⬇️

[Bridging between molecular biology and clinical aspect of respiratory tract diseases: discussion]

[Clinical evaluation of molecular-target based drug]